Therapeutic Monitoring of Infliximab and Adalimumab
Condition: Inflammatory Bowel Diseases Interventions: Drug: Infliximab; Drug: Adalimumab Sponsor: IRCCS Burlo Garofolo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials